This protective role of diabetes on prostate cancer may be explained in terms of decreased levels of insulin-like growth factor I (IGF-I) which have been reported in diabetic patients with hyperinsulinemia by some studies [16-19] In addition, chronic hyperinsulinemia was found to be inversely associated with plasma testosterone levels [20]. This evidence concerns the gene IGF1 and prostate cancer.